Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

PARIS (Reuters) - Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its ...

Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...

category Sanofi enters exclusive talks with CD&R for Opella sale 5:32 AM UTC · Updated ago Macro Matterscategory IMF, World ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

The FDA has approved Astellas' Vyloy to treat gastric cancer. Egypt has been certified malaria-free by WHO. A Tennessee court ...

Clayton Dubilier & Rice is set to buy Sanofi's consumer health unit with social commitments, including job creation ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...